New York Cancer & Blood
Lake Success Medical Oncology
New Hyde Park, NY
Filters
Save & Share
Clear Filters
Diagnosis
Treatment History
Accepting patients
CERVINO
A Phase 3, Multicenter, Randomized, Open Label Study of ABBV-383 Compared With Standard Available Therapies in Subjects With Relapsed or Refractory Multiple Myeloma (3L+ RRMM Monotherapy Study)
Learn more- Bispecific Antibody
- BCMA
- CD3
- Randomization
- Phase 3
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trials